High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$38.4M
$38,406,266
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-10 | $285,673 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-09 | $457,617 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-06 | $468,447 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Sell to CoverΔOwn -10.6%
2026-03-05
$574,537
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Sell to CoverΔOwn -10.6%
|
2026-03-05 | $574,537 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-05 | $495,056 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-04 | $513,621 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
GRIFFIN MICHELLE RENEE
• Director
10b5-1 SellΔOwn -75.7%
2026-03-03
$735,073
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Director
10b5-1 SellΔOwn -75.7%
|
2026-03-03 | $735,073 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $823,826x2 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-03-03
$235,129
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-03-03 | $235,129 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-03 | $484,751x2 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS CHAD M
• CEO
10b5-1 SellΔOwn -12.7%
2026-03-02
$4,572,360Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 SellΔOwn -12.7%
|
2026-03-02 | $4,572,360Large | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-03-02
$157,200
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-03-02 | $157,200 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2026-02-27 | $2,924,427Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
10b5-1 Sell
|
2026-02-04 | $39,597 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-03
$154,280
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-03 | $154,280 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2026-02-02 | $2,304,963Large | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-02
$644,825
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-02 | $644,825 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
10b5-1 SellΔOwn -20.1%
2026-01-12
$1,411,131Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
10b5-1 SellΔOwn -20.1%
|
2026-01-12 | $1,411,131Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
10b5-1 Sell
|
2026-01-12 | $77,220 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-01-06
$164,400
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-01-06 | $164,400 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
10b5-1 SellΔOwn -26.5%
2025-12-15
$1,773,267Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
10b5-1 SellΔOwn -26.5%
|
2025-12-15 | $1,773,267Large | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
HERSHBERG ROBERT
• Director
Discretionary SellΔOwn -33.0%
2025-12-10
$367,488
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Director
Discretionary SellΔOwn -33.0%
|
2025-12-10 | $367,488 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
10b5-1 Sell
2025-12-04
$212,377
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
10b5-1 Sell
|
2025-12-04 | $212,377 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-12-04
$166,100
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-12-04 | $166,100 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-12-03
$506,415
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-12-03 | $506,415 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2025-12-01 | $2,367,462Large | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
PISKEL KYLE
• CFO
10b5-1 SellΔOwn -42.9%
2025-11-28
$3,174,990Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
10b5-1 SellΔOwn -42.9%
|
2025-11-28 | $3,174,990Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2025-11-26 | $703,284 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -51.0%
2025-11-21
$5,216,346Whale
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -51.0%
|
2025-11-21 | $5,216,346Whale | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
BENZENO SHARON
• Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -50.1%
2025-11-20
$4,927,680Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Commercial Ofc Imm Med
10b5-1 SellΔOwn -50.1%
|
2025-11-20 | $4,927,680Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Sell to Cover
|
2025-11-17 | $3,344 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2025-11-12 | $28,005 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2025-11-11 | $18,023 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2025-11-10 | $1,269,152Large | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-11-10
$148,200
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-11-10 | $148,200 | S | Form 4 |